Kurs & Likviditet
Beskrivning
Land | Norge |
---|---|
Lista | Euronext Growth Oslo |
Sektor | Hälsovård |
Industri | Medicinteknik |
2022-12-09 13:11:24
An extraordinary general meeting of SoftOx Solutions AS (the "Company") was held
today on 9 December 2022 at 12.00. The general meeting was held both as a
physical and electronic meeting. 2 806 781 shares were represented,
corresponding to 27,14 % of the Company's total number of shares.
The general meeting approved all the proposals on the agenda in line with the
notice dated 2 December 2022. The board of directors has now been strengthened
with the additions of Henrik Nielsen, Adrian Bignami and Jørgen Berggrav,
together with the existing members Kari Myren and Olav Jarlsby. CEO, Geir Almås,
steps up to become full-time Executive Chairman of the Board. He will therefore
resign as CEO as soon as the new board has appointed an interim CEO.
Signed minutes from the general meeting are attached to this announcement and
will be made available on the Company's website.
For further information, please contact:
CEO Geir Almås of SoftOx Solutions AS
Mail: ir@soft-ox.com
Mobile: (+47) 948 59 599
About SoftOx Solutions AS
SoftOx Solutions AS (SoftOx, listed on Euronext Growth Oslo) is a medtech and
clinical-stage pharmaceutical company based in Oslo, Norway, with the goal of
reducing the spread of infection and emergence of antimicrobial resistance.
For more information on SoftOx, visit www.soft-ox.com